Ventripoint signs LG deal to support VMS+ rollout

Executive Summary

• Ventripoint Diagnostics Ltd. has entered into a memorandum of understanding and consulting agreement with LG Consulting Solutions to support the commercialization and deployment of its VMS+ AI-enhanced echocardiography system in Northern California.
• LG Consulting Solutions will provide economic analysis, clinical implementation support, and health system business case development to assist hospitals in adopting the technology.
• The agreement includes LG purchasing a VMS+ system for use as a demonstration platform and includes potential revenue sharing related to 3-D echocardiography processing services.

Key Details

• Parties: Ventripoint Diagnostics Ltd. and LG Consulting Solutions.
• Agreement Type: Memorandum of Understanding and Consulting Agreement.
• Scope: Commercialization and deployment of the VMS+ system in the Northern California region (specifically Sacramento and San Francisco).
• LG Consulting Services:
  • Economic analysis.
  • Clinical implementation support.
  • Health system business case development.
  • Outcomes evaluation.
  • Implementation planning.
  • Continuing operational support.
• Equipment: LG Consulting Solutions is purchasing a VMS+ system to serve as a demonstration and implementation platform for hospital engagement, clinician training, and economic value assessments.
• Financial Terms: The agreement includes potential revenue sharing related to 3-D echocardiography processing services associated with accounts supported by the consulting engagement.
• Strategic Rationale: To demonstrate the economic and clinical value of AI-enhanced echocardiography imaging and workflow integration to healthcare systems.

Notable Quotes

• Hugh MacNaught, President and CEO, Ventripoint Diagnostics Ltd.: "Economic and operational clarity are critical to accelerating the adoption of new medical technologies. This collaboration will help hospitals clearly evaluate how VMS+ can improve cardiac care pathways, enhance clinical insight into cardiac function and support better patient care while delivering measurable value to health care systems."
• Lori Gallian, Principal, LG Consulting: "Health care systems increasingly require clear clinical and economic evidence before adopting new technologies. Through this collaboration, we will work directly with cardiac programs to develop practical implementation strategies and demonstrate how VMS+ can deliver both clinical and operational benefits."